Pharvaris (PHVS) Capital Expenditures (2020 - 2026)
Pharvaris (PHVS) reported Capital Expenditures of -$31,276 for Q2 2026, compared with $18,831 a year earlier.
Powered by 
Analysis
Pharvaris (PHVS) Capital Expenditures (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Pharvaris' Capital Expenditures came in at -$115,936; for FY2025, it came in at -$185,988.
- By year, Capital Expenditures came in at -$582,391 in FY2024, -$97,337 in FY2023, -$131,003 in FY2022 and -$153,880 in FY2021.
- Five-year quarterly Capital Expenditures spans a low of -$76.29 billion in Q2 2024 and a high of $77.8 billion in Q3 2024.
- Per Business Quant data, the three quarters before Q2 2026 came in at -$60,992 (Q1 2026), -$1,790 (Q4 2025) and -$21,878 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Pharvaris | 2.08 Bn | -289,124.32 Bn | 85,072.10 | -31,275.67 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -31,275.67 |
| Mar 31, 2026 | -60,992.34 |
| Dec 31, 2025 | -1,790.30 |
| Sep 30, 2025 | -21,877.70 |
| Jun 30, 2025 | 18,831.28 |
| Mar 31, 2025 | -169,356.55 |
| Dec 31, 2024 | -171,955.17 |
| Sep 30, 2024 | 77.80 Bn |
| Jun 30, 2024 | -76.29 Bn |
| Mar 31, 2024 | -33,360.00 |
| Dec 31, 2023 | -30,535.17 |
| Sep 30, 2023 | 58.91 Bn |
| Jun 30, 2023 | -58.93 Bn |
| Mar 31, 2023 | -20,434.28 |
| Dec 31, 2022 | -24,117.63 |
| Sep 30, 2022 | 50.15 Bn |
| Jun 30, 2022 | -53.07 Bn |
| Mar 31, 2022 | -29,598.29 |
| Dec 31, 2021 | -78,405.48 |
| Sep 30, 2021 | -32,949.29 |
API Access
Pharvaris Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=PHVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "PHVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=PHVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();